- Home
- LCNB vs RNAC Comparison
LCNB vs RNAC Comparison
Compare LCNB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCNB | RNAC |
|---|---|---|
| Founded | 1877 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.5M | 204.6M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | LCNB | RNAC |
|---|---|---|
| Price | $16.06 | $6.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.40 |
| AVG Volume (30 Days) | 20.3K | ★ 138.3K |
| Earning Date | 10-22-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.49% | N/A |
| EPS Growth | ★ 220.73 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $89,312,000.00 | $1,091,000.00 |
| Revenue This Year | $18.04 | N/A |
| Revenue Next Year | $4.36 | N/A |
| P/E Ratio | $9.60 | ★ N/A |
| Revenue Growth | ★ 19.58 | N/A |
| 52 Week Low | $13.34 | $5.98 |
| 52 Week High | $17.49 | $26.50 |
Technical Indicators
Market Signals| Indicator | LCNB | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 38.12 |
| Support Level | $15.55 | $6.53 |
| Resistance Level | $16.18 | $7.73 |
| Average True Range (ATR) | 0.36 | 0.43 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 78.71 | 29.23 |
Price Performance
Historical ComparisonAbout LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.